Metformin elicits anticancer effects through the sequential modulation of DICER and c-MYC

Giovanni Blandino, Mariacristina Valerio, Mario Cioce, +11

Nature Communications

Tumor BiologyOncologyChemoprevention StrategyMedicineSequential Modulation +8

SASP mediates chemoresistance and tumor-initiating-activity of mesothelioma cells

Claudia Canino, Federica Mori, A Cambria, +13

Oncogene

Malignant DiseaseMedicineCancer BiologyCell BiologyTumor Biology +1

miR-204 targets Bcl-2 expression and enhances responsiveness of gastric cancer

Andrea Sacconi, Francesca Biagioni, Valeria Canu, +20

Cell Death and Disease

MMP11: A Novel Target Antigen for Cancer Immunotherapy

Daniela Peruzzi, Federica Mori, Antonella Conforti, +5

Clinical Cancer Research

miR‐10b*, a master inhibitor of the cell cycle, is down‐regulated in human breast tumours

Francesca Biagioni, Noa Bossel Ben‐Moshe, Giulia Fontemaggi, +16

EMBO Molecular Medicine

Protumorigenic effects of mir-145 loss in malignant pleural mesothelioma

Mario Cioce, Federica Ganci, Valeria Canu, +18

Oncogene

PathologyMir-145 LossMicrorna DetectionMedicineCancer Research +2

Revealing New Mouse Epicardial Cell Markers through Transcriptomics

Lars Bochmann, Padmini Sarathchandra, Federica Mori, +3

PLoS ONE

Epigenetic silencing of miR-145-5p contributes to brain metastasis

Sara Donzelli, Federica Mori, Teresa Bellissimo, +15

Oncotarget

Immune Profiling of Premalignant Lesions in Patients With Lynch Syndrome

Kyle Chang, Melissa W. Taggart, Laura Reyes-Uribe, +18

JAMA Oncology

A Genetic Vaccine Encoding Shared Cancer Neoantigens to Treat Tumors with Microsatellite Instability

Guido Leoni, Anna Morena D’Alise, Gabriella Cotugno, +28

Cancer Research